http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-100751051-B1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-258 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-704 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-704 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-70 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P19-02 |
| filingDate | 2005-12-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2007-08-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2007-08-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-100751051-B1 |
| titleOfInvention | Pharmaceutical composition for the treatment of arthritis |
| abstract | The invention (a) 20- O -β-D- glucopyranosyl -20 (S) of the following formula (I) as an active ingredient-protocol Panax Oh diol (20- O -β-D-glucopyranosyl -20 (S) - protopanaxadiol) or a therapeutically effective amount thereof; And (b) a pharmaceutically acceptable carrier.n n n n Formula 1n n n n n n n n n n 20-O-β-D-glucopyranosyl-20 (S) -protopanaxadiol, compound K, saponin, ginsenosides, arthritis, osteoarthritis |
| priorityDate | 2004-12-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 90.